Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Amwell, a leader in telehealth, announced the appointment of Brendan O’Grady as Chief Commercial & Growth Officer. Effective immediately, O'Grady brings over 30 years of healthcare experience, having previously served as President and CEO of Teva Pharmaceuticals' North America Business. He will focus on driving growth initiatives and expanding Amwell's market strategy. Chairman Ido Schoenberg emphasized O'Grady's significant contributions as a board member since 2015 and his proven ability to lead healthcare organizations towards strategic growth.
Amwell (NYSE: AMWL) will report its second quarter operating results for the period ending June 30, 2021, on August 11, 2021. Following the release, the management team will host a live conference call at 5:00 PM ET to discuss the results and provide a business update. Investors can access the call via the Company’s website or by calling in. Amwell is a leading telehealth platform connecting healthcare providers and patients, supporting a range of telehealth needs for over 2,000 hospitals and 55 health plans, covering over 80 million lives.
Amwell (NYSE: AMWL), a leading telehealth provider, announced that Ido Schoenberg and Keith Anderson will participate in the 42nd Annual Goldman Sachs Global Healthcare Conference. The fireside chat is scheduled for June 9, 2021, at 9:40 a.m. ET. A live audio webcast will be available in the investors section of Amwell's website and archived for approximately 90 days.
Amwell connects providers, insurers, and patients, offering a comprehensive telehealth platform that covers over 80 million lives through partnerships with more than 2,000 hospitals and 55 health plans.
Amwell, a national telehealth leader, reported robust financial results for Q1 2021, highlighting a surge in total active providers to approximately 81,000 from 24,000 a year prior. Total visits reached around 1.6 million, double the previous year. The company generated total revenue of $57.6 million, up from $53.7 million, with subscription revenue rising to $24.6 million. However, gross margin slightly declined to 38.0%, and net loss widened to $39.8 million. The company maintains a 2021 revenue outlook of $260-$270 million and an adjusted EBITDA between -$157 million and -$147 million.
Amwell (NYSE: AMWL) has announced its annual Client Awards, recognizing organizations that have excelled in telehealth amidst the COVID-19 pandemic. Awards were given in four categories: Empowering Providers, New Models, New Normal, Innovative Integrations, and Positive Impact. The winners demonstrated significant advancements in healthcare delivery, promoting equality and enhanced patient care through innovative practices. With over 36,000 employers and 80 million lives covered, Amwell continues to be a leader in telehealth solutions.
Amwell, a leader in telehealth (NYSE: AMWL), introduced its next-generation Converge telehealth platform at its annual Client Forum. This platform aims to enhance connectivity among healthcare providers, offering a unified care experience through flexibility and scalability. It incorporates features from notable partners like Google Cloud and TytoCare, ensuring improved patient engagement and diagnosis. The Converge platform's open architecture allows clients to customize their capabilities while ensuring a seamless integration with existing healthcare systems, ultimately facilitating better health outcomes.
Amwell, a leader in telehealth (NYSE: AMWL), will announce its first quarter operating results for the period ending March 31, 2021, on May 12, 2021. Following the release, the management team will hold a conference call and webcast at 5:00 p.m. ET to discuss the results and provide a business update. Investors can access the webcast via the Company’s website or listen via phone by calling (833) 979-2840 (U.S.) or (236) 384-2051 (International), using conference ID 4793448. A replay will be available for 90 days post-call.
Amwell®, a leader in telehealth, reported strong fourth-quarter and full-year financial results for 2020. The total active providers surged to ~72,000 from ~7,000 the previous year, and total visits reached ~1.6 million, up from 355,000. Total revenue rose to $60.4 million, compared to $45.0 million, while subscription and visit revenues increased significantly. Despite these gains, the net loss widened to $50.6 million from $22.7 million. For 2021, Amwell anticipates revenue between $260 million and $270 million and AMG visits of 1.5 to 1.7 million.
Amwell (NYSE: AMWL), a leader in telehealth, has joined the Moving Health Home coalition to advance home-based care delivery. This initiative aims to unite stakeholders to enhance home care sustainability, particularly for seniors with chronic conditions. Notably, home-based care can significantly reduce healthcare costs and improve patient outcomes. Amwell's commitment emphasizes the need for a hybrid care model following lessons learned during the pandemic. The company aims to create a healthcare system that enhances quality of life for patients.
Amwell (NYSE: AMWL), a leader in telehealth, will report its fourth quarter and full year operating results for 2020 on March 24, 2021. A live conference call and webcast will follow at 5:00 p.m. ET to discuss these results and provide a business update. Interested parties can access the webcast via the investors.amwell.com website or call (833) 979-2840 for the live call. The company supports over 2,000 hospitals and 55 health plans, covering 80 million lives with telehealth solutions.
FAQ
What is the current stock price of American Well (AMWL)?
What is the market cap of American Well (AMWL)?
